Open Nav

Genisphere LLC

  • Tom Bliss, Genisphere

Raise Capital

  • Date:Wednesday, October 17
  • Time:2:45 PM - 3:00 PM
  • Room:Elizabethan B
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Genisphere provides an innovative DNA-based targeted drug delivery platform called 3DNA®. Genisphere seeks additional partnerships with biotechnology and pharmaceutical companies that could benefit from the company's platform technology, which is IP-protected and fully customizable to deliver small molecules, biologics, and nucleic acids in a highly targeted manner.
  • Company
  • Company HQ City:Hatfield, PA, USA
  • Company HQ Country:United States
  • Company HQ State:Pennsylvania           
  • CEO/Top Company Official:Tom Bliss
  • Year Founded:1997
  • Main Therapeutic Focus:Oncology
  • Lead Product in Development :3DNA:siHuR:FA
  • Development Phase of Primary Product:Pre-Clinical
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :2
  • Additional Information/Comments:We are raising $16m in 2018 to complete the transition of Genisphere from its legacy in reagents, tools and diagnostics to its future in 3DNA-Based Therapeutics.
  • Previous and Current Investors:Corporate Fuel Private Equity
  • Size of Last Investment Round:$5m
  • Total Amount Raised to Date, In All Rounds:$15m
Tom Bliss